DK3906066T3 - Geneterapikonstruktioner til behandling af wilsons sygdom - Google Patents
Geneterapikonstruktioner til behandling af wilsons sygdom Download PDFInfo
- Publication number
- DK3906066T3 DK3906066T3 DK20704633.5T DK20704633T DK3906066T3 DK 3906066 T3 DK3906066 T3 DK 3906066T3 DK 20704633 T DK20704633 T DK 20704633T DK 3906066 T3 DK3906066 T3 DK 3906066T3
- Authority
- DK
- Denmark
- Prior art keywords
- wilson
- disease
- treatment
- gene therapy
- therapy constructs
- Prior art date
Links
- 208000002972 Hepatolenticular Degeneration Diseases 0.000 title 1
- 208000018839 Wilson disease Diseases 0.000 title 1
- 238000001415 gene therapy Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
- A61K48/0058—Nucleic acids adapted for tissue specific expression, e.g. having tissue specific promoters as part of a contruct
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Plant Pathology (AREA)
- Virology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962788324P | 2019-01-04 | 2019-01-04 | |
| US201962834830P | 2019-04-16 | 2019-04-16 | |
| PCT/US2020/012131 WO2020142653A1 (en) | 2019-01-04 | 2020-01-03 | Gene therapy constructs for treating wilson disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3906066T3 true DK3906066T3 (da) | 2024-02-05 |
Family
ID=69528954
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK20704633.5T DK3906066T3 (da) | 2019-01-04 | 2020-01-03 | Geneterapikonstruktioner til behandling af wilsons sygdom |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20220090131A1 (da) |
| EP (2) | EP4269579A3 (da) |
| JP (2) | JP2022516283A (da) |
| KR (1) | KR20210112339A (da) |
| CN (1) | CN113518628A (da) |
| AU (1) | AU2020204679A1 (da) |
| BR (1) | BR112021013140A2 (da) |
| CA (1) | CA3124880A1 (da) |
| CO (1) | CO2021010088A2 (da) |
| DK (1) | DK3906066T3 (da) |
| ES (1) | ES2970216T3 (da) |
| FI (1) | FI3906066T3 (da) |
| HR (1) | HRP20231750T1 (da) |
| IL (1) | IL284554A (da) |
| MX (1) | MX2021008135A (da) |
| PT (1) | PT3906066T (da) |
| SG (1) | SG11202106855YA (da) |
| TW (1) | TW202043479A (da) |
| WO (1) | WO2020142653A1 (da) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20230160411A (ko) | 2016-12-30 | 2023-11-23 | 더 트러스티스 오브 더 유니버시티 오브 펜실베니아 | 윌슨병을 치료하기 위한 유전자 치료 |
| EP3774854A1 (en) | 2018-04-03 | 2021-02-17 | Stridebio, Inc. | Antibody-evading virus vectors |
| TW202102525A (zh) | 2019-03-21 | 2021-01-16 | 美商史崔德生物公司 | 重組腺相關病毒載體 |
| EP3969597A4 (en) * | 2019-05-14 | 2023-01-25 | Duke University | COMPOSITIONS AND METHODS FOR THE TREATMENT OF ATPASE-MEDIATED DISEASES |
| MX2022004352A (es) | 2019-10-17 | 2022-07-19 | Stridebio Inc | Vectores virales adenoasociados para el tratamiento de la enfermedad de niemann-pick tipo c. |
| CN115216481A (zh) * | 2021-04-21 | 2022-10-21 | 四川至善唯新生物科技有限公司 | 一种表达量提高的截短型atp7b基因及其应用 |
| CN113694218A (zh) * | 2021-08-30 | 2021-11-26 | 昆明理工大学 | 一种atp7b基因p992l突变的基因修复治疗载体 |
| WO2023108159A1 (en) * | 2021-12-10 | 2023-06-15 | University Of Florida Research Foundation, Incorporated | Methods and compositions for treating bag-3 related cardiomyopathy with a viral vector |
| WO2023108130A2 (en) * | 2021-12-10 | 2023-06-15 | Aavantibio, Inc. | Compositions comprising kozak sequences selected for enhanced expression |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6759050B1 (en) | 1998-12-03 | 2004-07-06 | Avigen, Inc. | Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith |
| CA2406745C (en) | 2001-11-13 | 2006-01-10 | The Trustees Of The University Of Pennsylvania | A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby |
| DK1453547T3 (da) | 2001-12-17 | 2016-12-05 | Univ Pennsylvania | Adenoassocieret virus (aav)-serotype 8-sekvenser, vektorer indeholdende disse og anvendelser deraf |
| DK2277996T3 (da) | 2003-05-21 | 2014-10-20 | Genzyme Corp | Fremgangsmåder til fremstilling af præparationer af rekombinante aav-virioner, der i hovedsagen er fri for tomme capsider |
| AU2004278684B2 (en) | 2003-09-30 | 2011-05-12 | The Trustees Of The University Of Pennsylvania | Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses therefor |
| CN112029737A (zh) | 2005-04-07 | 2020-12-04 | 宾夕法尼亚大学托管会 | 增强腺相关病毒载体功能的方法 |
| WO2009097129A1 (en) | 2008-01-29 | 2009-08-06 | Applied Genetic Technologies Corporation | Recombinant virus production using mammalian cells in suspension |
| US8679837B2 (en) | 2009-04-02 | 2014-03-25 | University Of Florida Research Foundation, Inc. | Inducible system for highly efficient production of recombinant Adeno-associated virus (rAAV) vectors |
| US8734809B2 (en) | 2009-05-28 | 2014-05-27 | University Of Massachusetts | AAV's and uses thereof |
| BR112012018899A2 (pt) | 2010-01-28 | 2015-09-15 | Philadelphia Children Hospital | "método para purificar partículas de vetor de vírus adeno-associado." |
| US8927514B2 (en) | 2010-04-30 | 2015-01-06 | City Of Hope | Recombinant adeno-associated vectors for targeted treatment |
| CN114231563A (zh) * | 2014-05-02 | 2022-03-25 | 建新公司 | 用于视网膜及cns基因疗法的aav载体 |
| EP3198018B1 (en) | 2014-09-24 | 2020-12-09 | City of Hope | Adeno-associated virus vector variants for high efficiency genome editing and methods thereof |
| JP6865167B2 (ja) * | 2014-12-17 | 2021-04-28 | フンダシオン パラ ラ インベスティガシオン メディカ アプリカダ | ウィルソン病の処置に使用するための核酸構築物及び遺伝子治療ベクター |
| KR20230160411A (ko) * | 2016-12-30 | 2023-11-23 | 더 트러스티스 오브 더 유니버시티 오브 펜실베니아 | 윌슨병을 치료하기 위한 유전자 치료 |
| WO2023230466A1 (en) * | 2022-05-23 | 2023-11-30 | Lutsenka Svetlana | Compositions and methods for treating wilson's disease |
-
2020
- 2020-01-03 ES ES20704633T patent/ES2970216T3/es active Active
- 2020-01-03 DK DK20704633.5T patent/DK3906066T3/da active
- 2020-01-03 TW TW109100147A patent/TW202043479A/zh unknown
- 2020-01-03 HR HRP20231750TT patent/HRP20231750T1/hr unknown
- 2020-01-03 EP EP23196931.2A patent/EP4269579A3/en active Pending
- 2020-01-03 JP JP2021538754A patent/JP2022516283A/ja active Pending
- 2020-01-03 FI FIEP20704633.5T patent/FI3906066T3/fi active
- 2020-01-03 KR KR1020217024152A patent/KR20210112339A/ko unknown
- 2020-01-03 CN CN202080007863.5A patent/CN113518628A/zh active Pending
- 2020-01-03 EP EP20704633.5A patent/EP3906066B1/en active Active
- 2020-01-03 SG SG11202106855YA patent/SG11202106855YA/en unknown
- 2020-01-03 PT PT207046335T patent/PT3906066T/pt unknown
- 2020-01-03 US US17/417,619 patent/US20220090131A1/en active Pending
- 2020-01-03 CA CA3124880A patent/CA3124880A1/en active Pending
- 2020-01-03 WO PCT/US2020/012131 patent/WO2020142653A1/en unknown
- 2020-01-03 BR BR112021013140A patent/BR112021013140A2/pt unknown
- 2020-01-03 MX MX2021008135A patent/MX2021008135A/es unknown
- 2020-01-03 AU AU2020204679A patent/AU2020204679A1/en active Pending
-
2021
- 2021-07-01 IL IL284554A patent/IL284554A/en unknown
- 2021-07-29 CO CONC2021/0010088A patent/CO2021010088A2/es unknown
-
2024
- 2024-03-01 JP JP2024031460A patent/JP2024054426A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| IL284554A (en) | 2021-08-31 |
| US20220090131A1 (en) | 2022-03-24 |
| TW202043479A (zh) | 2020-12-01 |
| BR112021013140A2 (pt) | 2021-11-30 |
| SG11202106855YA (en) | 2021-07-29 |
| JP2024054426A (ja) | 2024-04-16 |
| KR20210112339A (ko) | 2021-09-14 |
| CO2021010088A2 (es) | 2021-09-20 |
| PT3906066T (pt) | 2024-02-06 |
| WO2020142653A1 (en) | 2020-07-09 |
| EP4269579A2 (en) | 2023-11-01 |
| JP2022516283A (ja) | 2022-02-25 |
| AU2020204679A1 (en) | 2021-07-15 |
| HRP20231750T1 (hr) | 2024-05-24 |
| EP3906066A1 (en) | 2021-11-10 |
| ES2970216T3 (es) | 2024-05-27 |
| EP3906066B1 (en) | 2023-11-01 |
| FI3906066T3 (fi) | 2024-01-30 |
| CA3124880A1 (en) | 2020-07-09 |
| MX2021008135A (es) | 2021-08-11 |
| EP4269579A3 (en) | 2024-01-24 |
| CN113518628A (zh) | 2021-10-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3906066T3 (da) | Geneterapikonstruktioner til behandling af wilsons sygdom | |
| MA54229A (fr) | Composés et compositions destinés au traitement d'états pathologiques associés à une activité de nlrp | |
| DK3364997T3 (da) | Aspartoacylase genterapi til behandling af canavans sygdom | |
| DK3720433T3 (da) | Bis-cholin-tetrathiomolybdat til behandling af wilsons sygdom | |
| EP3562514A4 (en) | GENE THERAPY TO TREAT WILSON'S DISEASE | |
| DK3233129T3 (da) | Nukleinsyrekonstrukter og genterapivektorer til anvendelse i behandlingen af wilsons sygdom og andre lidelser | |
| IL285782A (en) | Compounds, compositions, and methods for treating disease | |
| SG11202011018PA (en) | 1,3-thiazol-2-yl substituted benzamides for the treatment of diseases associated with nerve fiber sensitization | |
| PH12020551043A1 (en) | Compounds, compositions, and methods for treatment of diseases involving acidic or hypoxic diseased tissues | |
| SG11202011296VA (en) | Compositions and methods for the treatment of parkinson's disease | |
| SG11202011010YA (en) | 1,3-thiazol-2-yl substituted benzamides for the treatment of diseases associated with nerve fiber sensitization | |
| MA56047A (fr) | Composés et compositions destinés au traitement d'états pathologiques associés à une activité de sting | |
| MX2017009417A (es) | Formas solidas de acido 2-(5-(3-fluorofenil)-3-hidroxipicolinamido )acetico, composiciones y usos de las mismas. | |
| EP4009948A4 (en) | USE OF TGF-ALPHA POLYPEPTIDE OR ANTI-TGF-ALPHA ANTIBODIES TO TREAT DISEASES AND DISORDERS | |
| IL284414A (en) | Methods and preparations for the treatment of Fabry disease | |
| EP3880809A4 (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF WILSON'S DISEASE | |
| WO2018067520A3 (en) | Therapeutic agents and methods: | |
| DK3749308T3 (da) | Behandling af patienter med klassisk fabrys sygdom med migalastat | |
| IL287796A (en) | Preparations and methods for the treatment of diseases mediated by ATPase | |
| EA201792571A1 (ru) | Терапевтическое применение l-4-хлорокинуренина | |
| IL285452A (en) | A new recombinant diamine oxidase and its use in the treatment of diseases characterized by excess histamine | |
| IL281244A (en) | Therapeutic combination for the treatment of liver diseases | |
| ZA202205344B (en) | Gene therapy for alzheimer's disease | |
| ZA202101489B (en) | Compositions and methods for the treatment of parkinson's disease | |
| EP3429569A4 (en) | METHODS FOR PREVENTING OR TREATING PARKINSON'S DISEASE BY FARNESYLATION DE PARIS |